(+)-schisandrin B multiple interactions ISO RGD:708558 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOL3 mRNA] CTD PMID:31150632 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:708558 6480464 o more ... CTD PMID:22937105 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of NOL3 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:708558 6480464 1-Naphthylisothiocyanate results in increased expression of NOL3 mRNA CTD PMID:30723492 17beta-estradiol affects expression ISO RGD:1352407 6480464 Estradiol affects the expression of NOL3 mRNA CTD PMID:21826169 17beta-estradiol decreases expression ISO RGD:1352407 6480464 Estradiol results in decreased expression of NOL3 mRNA CTD PMID:23373633 1H-pyrazole increases expression EXP 6480464 pyrazole results in increased expression of NOL3 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20005886 , PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [2 more ... CTD PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [2 more ... CTD PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:708558 6480464 Tetrachlorodibenzodioxin results in increased expression of NOL3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NOL3 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression ISO RGD:708558 6480464 2, 4-dinitrotoluene affects the expression of NOL3 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:708558 6480464 2, 6-dinitrotoluene affects the expression of NOL3 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:708558 6480464 3 more ... CTD PMID:23196670 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NOL3 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1352407 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NOL3 protein CTD PMID:34186270 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of NOL3 mRNA CTD PMID:28973697 acetamide increases expression ISO RGD:708558 6480464 acetamide results in increased expression of NOL3 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:708558 6480464 Acrylamide results in decreased expression of NOL3 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1352407 6480464 Acrylamide results in decreased expression of NOL3 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:708558 6480464 Aflatoxin B1 results in increased expression of NOL3 mRNA CTD PMID:23630614 , PMID:25378103 aldosterone decreases phosphorylation ISO RGD:708558 6480464 Aldosterone results in decreased phosphorylation of NOL3 protein CTD PMID:19001025 all-trans-retinoic acid increases expression ISO RGD:1352407 6480464 Tretinoin results in increased expression of NOL3 mRNA CTD PMID:23724009 ammonium chloride affects expression ISO RGD:708558 6480464 Ammonium Chloride affects the expression of NOL3 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:1352407 6480464 Antimycin A results in decreased expression of NOL3 mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:1352407 6480464 aristolochic acid I results in decreased expression of NOL3 mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:1352407 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of NOL3 mRNA CTD PMID:16934159 arsenous acid decreases response to substance ISO RGD:1352407 6480464 NOL3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 beauvericin increases expression ISO RGD:1352407 6480464 beauvericin results in increased expression of NOL3 mRNA CTD PMID:29203277 benzo[a]pyrene decreases expression ISO RGD:708558 6480464 Benzo(a)pyrene results in decreased expression of NOL3 mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO RGD:1352407 6480464 Benzo(a)pyrene results in increased methylation of NOL3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of NOL3 mRNA CTD PMID:22228805 , PMID:32417428 beta-naphthoflavone multiple interactions ISO RGD:708558 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOL3 mRNA CTD PMID:18164116 bexarotene multiple interactions ISO RGD:708558 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of NOL3 mRNA CTD PMID:17630414 bisphenol A affects expression ISO RGD:1352407 6480464 bisphenol A affects the expression of NOL3 mRNA CTD PMID:21826169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NOL3 mRNA CTD PMID:32156529 bisphenol A increases expression ISO RGD:1352407 6480464 bisphenol A results in increased expression of NOL3 protein CTD PMID:34186270 bisphenol A increases methylation ISO RGD:1352407 6480464 bisphenol A results in increased methylation of NOL3 gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:708558 6480464 bisphenol A results in increased methylation of NOL3 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:708558 6480464 bisphenol A results in increased expression of NOL3 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1352407 6480464 bisphenol F results in increased expression of NOL3 protein CTD PMID:34186270 Brevetoxin B increases expression ISO RGD:1352407 6480464 brevetoxin 2 results in increased expression of NOL3 mRNA CTD PMID:20498034 butanal decreases expression ISO RGD:1352407 6480464 butyraldehyde results in decreased expression of NOL3 mRNA CTD PMID:26079696 caffeine decreases phosphorylation ISO RGD:1352407 6480464 Caffeine results in decreased phosphorylation of NOL3 protein CTD PMID:35688186 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of NOL3 mRNA CTD PMID:32715474 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NOL3 mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1352407 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of NOL3 mRNA CTD PMID:27392435 cobalt atom multiple interactions ISO RGD:1352407 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of NOL3 mRNA CTD PMID:18078969 cobalt dichloride increases expression ISO RGD:708558 6480464 cobaltous chloride results in increased expression of NOL3 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1352407 6480464 [NSC 689534 binds to Copper] which results in increased expression of NOL3 mRNA CTD PMID:20971185 copper atom decreases expression ISO RGD:708558 6480464 Copper results in decreased expression of NOL3 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1352407 6480464 [NSC 689534 binds to Copper] which results in increased expression of NOL3 mRNA CTD PMID:20971185 copper(0) decreases expression ISO RGD:708558 6480464 Copper results in decreased expression of NOL3 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1352407 6480464 Copper Sulfate results in increased expression of NOL3 mRNA CTD PMID:19549813 coumarin increases expression ISO RGD:708558 6480464 coumarin results in increased expression of NOL3 mRNA CTD PMID:18480146 coumarin increases phosphorylation ISO RGD:1352407 6480464 coumarin results in increased phosphorylation of NOL3 protein CTD PMID:35688186 cyclosporin A decreases expression ISO RGD:1352407 6480464 Cyclosporine results in decreased expression of NOL3 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1352407 6480464 Cyclosporine results in increased expression of NOL3 mRNA CTD PMID:25562108 cypermethrin increases expression ISO RGD:1352407 6480464 cypermethrin results in increased expression of NOL3 mRNA CTD PMID:27704156 dexamethasone multiple interactions ISO RGD:708558 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of NOL3 mRNA] CTD PMID:20032058 dexamethasone increases expression ISO RGD:708558 6480464 Dexamethasone results in increased expression of NOL3 mRNA CTD PMID:20032058 diarsenic trioxide decreases response to substance ISO RGD:1352407 6480464 NOL3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diazinon affects expression ISO RGD:708558 6480464 Diazinon affects the expression of NOL3 mRNA CTD PMID:22546817 dioxygen increases expression ISO RGD:1352407 6480464 Oxygen deficiency results in increased expression of NOL3 mRNA CTD PMID:17914565 diuron decreases expression ISO RGD:708558 6480464 Diuron results in decreased expression of NOL3 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1352407 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:708558 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the reaction [Doxorubicin results in increased degradation of NOL3 protein] more ... CTD PMID:19139834 , PMID:19915844 doxorubicin decreases expression ISO RGD:1352407 6480464 Doxorubicin results in decreased expression of NOL3 mRNA CTD PMID:29803840 doxorubicin decreases response to substance ISO RGD:708558 6480464 NOL3 protein results in decreased susceptibility to Doxorubicin CTD PMID:19139834 doxorubicin increases expression ISO RGD:708558 6480464 Doxorubicin results in increased expression of NOL3 mRNA CTD PMID:19915844 doxorubicin decreases expression ISO RGD:708558 6480464 Doxorubicin results in decreased expression of NOL3 mRNA CTD PMID:19139834 elemental selenium multiple interactions ISO RGD:1352407 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA CTD PMID:19244175 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of NOL3 protein CTD PMID:19429258 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of NOL3 mRNA CTD PMID:30517762 ethanol multiple interactions ISO RGD:1352407 6480464 ALDH2 protein inhibits the reaction [Ethanol results in decreased expression of NOL3 protein] CTD PMID:19429258 ethyl methanesulfonate increases expression ISO RGD:1352407 6480464 Ethyl Methanesulfonate results in increased expression of NOL3 mRNA CTD PMID:23649840 flavonoids decreases expression ISO RGD:708558 6480464 Flavonoids results in decreased expression of NOL3 mRNA CTD PMID:18035473 flutamide increases expression ISO RGD:708558 6480464 Flutamide results in increased expression of NOL3 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 furan increases expression ISO RGD:708558 6480464 furan results in increased expression of NOL3 mRNA CTD PMID:20562052 more ... furosemide affects expression ISO RGD:708558 6480464 Furosemide affects the expression of NOL3 mRNA CTD PMID:17497460 glyphosate increases expression ISO RGD:1352407 6480464 glyphosate results in increased expression of NOL3 mRNA CTD PMID:31874349 GW 4064 decreases expression EXP 6480464 GW 4064 results in decreased expression of NOL3 mRNA CTD PMID:26655953 hydrogen peroxide decreases expression ISO RGD:708558 6480464 Hydrogen Peroxide results in decreased expression of NOL3 protein CTD PMID:16157298 indole-3-methanol affects expression ISO RGD:708558 6480464 indole-3-carbinol affects the expression of NOL3 mRNA CTD PMID:21396975 isoprenaline decreases phosphorylation ISO RGD:708558 6480464 Isoproterenol results in decreased phosphorylation of NOL3 protein CTD PMID:19001025 ivermectin decreases expression ISO RGD:1352407 6480464 Ivermectin results in decreased expression of NOL3 protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NOL3 mRNA CTD PMID:20938992 lactacystin multiple interactions ISO RGD:708558 6480464 lactacystin affects the reaction [Doxorubicin results in increased degradation of NOL3 protein] CTD PMID:19139834 lead(0) affects expression ISO RGD:1352407 6480464 Lead affects the expression of NOL3 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1352407 6480464 Lead affects the expression of NOL3 mRNA CTD PMID:28903495 mercury dibromide multiple interactions ISO RGD:1352407 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOL3 mRNA CTD PMID:27188386 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of NOL3 mRNA CTD PMID:18502557 methyl methanesulfonate increases expression ISO RGD:1352407 6480464 Methyl Methanesulfonate results in increased expression of NOL3 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1352407 6480464 methylmercuric chloride results in increased expression of NOL3 mRNA CTD PMID:28001369 methylphenidate decreases expression EXP 6480464 Methylphenidate results in decreased expression of NOL3 mRNA CTD PMID:22470460 Mitotane increases expression ISO RGD:708558 6480464 Mitotane results in increased expression of NOL3 mRNA CTD PMID:23485034 monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NOL3 mRNA CTD PMID:19001666 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:708558 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the reaction [Doxorubicin results in increased degradation of NOL3 protein] CTD PMID:19139834 N-nitrosodiethylamine multiple interactions ISO RGD:708558 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOL3 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:708558 6480464 Diethylnitrosamine results in increased expression of NOL3 mRNA CTD PMID:19638242 nickel atom decreases expression ISO RGD:1352407 6480464 Nickel results in decreased expression of NOL3 mRNA CTD PMID:24768652 nickel dichloride affects expression ISO RGD:708558 6480464 nickel chloride affects the expression of NOL3 mRNA CTD PMID:22546817 nitrofen increases expression ISO RGD:708558 6480464 nitrofen results in increased expression of NOL3 mRNA CTD PMID:26720608 oxaliplatin multiple interactions ISO RGD:708558 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NOL3 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:1352407 6480464 p-Chloromercuribenzoic Acid results in increased expression of NOL3 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1352407 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOL3 mRNA CTD PMID:27188386 p-menthan-3-ol increases expression ISO RGD:1352407 6480464 Menthol results in increased expression of NOL3 mRNA CTD PMID:26760959 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of NOL3 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1352407 6480464 Acetaminophen results in increased expression of NOL3 mRNA CTD PMID:21420995 paraquat decreases expression ISO RGD:1352407 6480464 Paraquat results in decreased expression of NOL3 mRNA CTD PMID:18836921 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of NOL3 mRNA CTD PMID:23091169 phenylephrine decreases phosphorylation ISO RGD:708558 6480464 Phenylephrine results in decreased phosphorylation of NOL3 protein CTD PMID:18171680 picoxystrobin decreases expression ISO RGD:1352407 6480464 picoxystrobin results in decreased expression of NOL3 mRNA CTD PMID:33512557 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of NOL3 mRNA CTD PMID:20813756 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NOL3 mRNA CTD PMID:18301758 more ... razoxane multiple interactions ISO RGD:708558 6480464 Razoxane inhibits the reaction [Doxorubicin results in increased expression of NOL3 mRNA] CTD PMID:19915844 rotenone decreases expression ISO RGD:1352407 6480464 Rotenone results in decreased expression of NOL3 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1352407 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1352407 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA CTD PMID:19244175 Soman increases expression ISO RGD:708558 6480464 Soman results in increased expression of NOL3 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1352407 6480464 Sunitinib results in increased expression of NOL3 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:708558 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of NOL3 mRNA CTD PMID:17630414 testosterone multiple interactions ISO RGD:708558 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of NOL3 mRNA] CTD PMID:20032058 tetrachloromethane multiple interactions ISO RGD:708558 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOL3 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:708558 6480464 Carbon Tetrachloride results in increased expression of NOL3 mRNA CTD PMID:30723492 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of NOL3 mRNA CTD PMID:30517762 thimerosal decreases expression ISO RGD:1352407 6480464 Thimerosal results in decreased expression of NOL3 mRNA CTD PMID:27188386 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of NOL3 mRNA CTD PMID:23557971 topotecan multiple interactions ISO RGD:708558 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NOL3 mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:708558 6480464 Topotecan results in increased expression of NOL3 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NOL3 mRNA CTD PMID:25549359 trichloroethene increases expression ISO RGD:708558 6480464 Trichloroethylene results in increased expression of NOL3 mRNA CTD PMID:33387578 Tungsten carbide multiple interactions ISO RGD:1352407 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of NOL3 mRNA CTD PMID:18078969 valproic acid decreases expression ISO RGD:1352407 6480464 Valproic Acid results in decreased expression of NOL3 mRNA CTD PMID:23179753 , PMID:29154799 valproic acid increases methylation ISO RGD:1352407 6480464 Valproic Acid results in increased methylation of NOL3 gene CTD PMID:29154799 vitamin E multiple interactions ISO RGD:1352407 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1352407 6480464 vorinostat results in decreased expression of NOL3 mRNA CTD PMID:27188386 zinc atom increases expression ISO RGD:1352407 6480464 Zinc deficiency results in increased expression of NOL3 mRNA CTD PMID:18356318 zinc(0) increases expression ISO RGD:1352407 6480464 Zinc deficiency results in increased expression of NOL3 mRNA CTD PMID:18356318
